CEO Today USA Awards

ABOUT JIMRATCLIFF James L. Ratcliff (Jim) Ph.D., is Chairman of the Board and CEO of Rowpar Pharmaceuticals, Inc., Scottsdale, AZ, maker of the ClōSYS brand of oral care products. Jim is a driving force behind expansion of the company’s product line and its penetration of global markets. Jim is the second generation of the Ratcliff family leading Rowpar. Prior to joining the company as Chairman and CEO in 2000, Jim served as senior research scientist, professor, and director of the Center for the Study of Higher Education at Pennsylvania State University. From 1979 to 1989, Jim served as professor and program head for higher education at Iowa State University. Dr. Ratcliff is author of 120 articles, books, and book chapters, and is the co-inventor on over 30 patents and patents pending. He is an active member of the Phoenix Committee on Foreign Relations, Arizona Biotechnology Association, American Academy of Oral and Systemic Health, American Education Research Association, Global Chamber, and the International Association for Dental Research. He holds a Ph.D. in Higher Education and a M.A. in History from Washington State University, and a B.A. from Utah State University. Headquartered in Scottsdale, Arizona since 1991, Rowpar Pharmaceuticals, Inc. is an organization dedicated to providing innovative oral health solutions; ClōSYS® Oral Health products help people live healthier lives, combatting the two world-wide epidemics, dental caries and periodontal disease. Originally envisioned as a company selling a boutique product line exclusively to dentists, Rowpar competes successfully in the world of fast-moving consumer goods, both nationally and internationally. With a team of fewer than a dozen seasoned professionals, Rowpar thrives in a world dominated by firms such as Colgate-Palmolive, Proctor & Gamble, and GlaxoSmithKline. Having broken new ground, ClōSYS products are dispensed by Novartis in the USA with Afinitor™ (breast cancer chemo) prescriptions to counteract medically induced oral sores. Dr. Perry Ratcliff, one of America’s leading periodontists and experts on dental health and gum disease, along with a team of leading dental professionals, founded Rowpar and created the initial formulas that became CloSYS. During the senior Dr. Ratcliff’s 50-plus years of clinical practice, he discovered that stabilized chlorine dioxide helped reduce harmful bacteria in the mouths of his patients, a discovery that has evolved into the patented formula Cloralstan®, the active ingredient that makes ClōSYS unique, safe and effective. Dr. Perry Ratcliff remained active in Rowpar’s development until the year 2000. Rowpar provides innovative oral health solutions to dental and medical professionals and the general consumer, helping people get well and stay well in North America, Europe, Australia, and Asia. The ClōSYS® brand is recommended by dentists and hygienists, doctors and nurses, and is among the top 10% of oral care products stocking the shelves in CVS, Walgreens, Walmart, Target, and Amazon nationally with new retailers, new stores, and new shelves continually being added. During 2019 and 2020, Rowpar introduced the first oral care system (toothpaste and oral rinse) for adults 55 and older. Seniors are prone to adult caries and periodontal disease in epidemic proportions. These diseases compromise the immune system, leaving seniors vulnerable to chronic, infectious systemic diseases. ClōSYS® Silver Toothpaste and ClōSYS® Silver Rinse are specially formulated for adults 55+. Not only are ClōSYS® Silver Toothpaste and Oral Rinses innovative in targeting the needs of the senior population, they present superior functionality for the user by providing unsurpassed remineralization, lowerabrasiveness,andreducedbiofilmregrowthcomparedtoleading brands and the USP Reference. Research supporting the efficacy of this product was presented at the International Association for Dental Research (IADR) meetings . With its increased functionality, the new Silver Toothpaste significantly surpasses the industry toothpaste leaders by targeting and meeting the emerging oral care needs of seniors. Both ClōSYS® Silver Toothpaste and Rinse have been reviewed by the Council on Scientific Affairs of the American Dental Association (ADA) and awarded their internationally recognized Seal of Acceptance. Recently, ClōSYS® Silver Oral Rinse was reviewed by the Clinicians’ Report, one of the dental industry’s most widely recognized independent product review organizations. they found the product effective in noted healing oral sores, strengthening enamel and eliminating bad breath, stating that 96% of dentists reviewing ClōSYS® Silver Oral Rinse would recommend this innovative product to their patients. In short, Rowpar developed and brought to market the first “oral care system” designed specifically for the oral health of seniors based on user insight, innovation, added functionality, and business impact. Rowpar’s motto is “Gentlest. Oral Care. Ever.®”, and its mission is to improve oral and systemic health worldwide. Cloralstan® is Rowpar’s patented core technology. ClōSYS products are proven effective in killing oral pathogens associated with plaque, gum and other oral diseases, and for reducing oral malodor, dry mouth, sensitive mouth, and oral mucositis resulting from chemotherapy all without impeding the healing process or killing bacteria beneficial to health. Yes, Gentlest. Oral Care. Ever.® Jim Ratcliff CEO of Rowpar Pharmaceuticals, Inc 16 CEO TODAY USA AWARDS 2020 www.rowpar.com